Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Final Guidance Encourages Use Of Patient Preference In Device Applications

Executive Summary

US FDA released a final guidance aimed at helping sponsors and other stakeholders interested in using patient-preference information to make their case for a device application. The agency has decided to keep its labeling recommendation in the final guidance despite industry objections.


Related Content

US FDA's Device-Focused Patient Engagement AdComm Tackles Trial Challenges
Benefit-Risk Calls On PMAs Based On Patient Pluses Versus Adverse-Event Chances, Guidance Says
Industry, US FDA Strike $1Bn Deal After Contentious User-Fee Negotiations
Firms Bristle At Labeling Requirements For Patient-Preference Data
CDRH Staff Credits Advocacy Groups For Patient Preference Guidance
US FDA consults on using patient experience to support approval of novel devices
MDIC Catalog Outlines Patient Preference Methods
Podcast: Med Device Consortium CEO On Patient Preference Report
Device Consortium Tries To Shed Light on Patient Risk-Benefit Preferences
FDA Weighs Patients' Risk Tolerance in Approving Obesity Device


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts